Search company, investor...

Founded Year

1997

Stage

IPO | IPO

Total Raised

$276.1M

Date of IPO

9/24/2021

Market Cap

0.05B

Stock Price

0.09

About Broncus Medical

Broncus Medical (HK:02216) develops technologies focused on diagnostic and therapeutic lung procedures. It delivers navigation, diagnostic & therapeutic technologies to treat patients with lung disease. The company was founded in 1997 and is based in San Jose, California.

Headquarters Location

125 Nicholson Lane

San Jose, California, 95134,

United States

5718-659-5016

Loading...

Loading...

Broncus Medical Patents

Broncus Medical has filed 54 patents.

The 3 most popular patent topics include:

  • respiratory therapy
  • muscarinic antagonists
  • combination drugs
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/4/2019

2/13/2024

Radiation therapy, Medical physics, Monoclonal antibodies, Lung disorders, Radiobiology

Grant

Application Date

2/4/2019

Grant Date

2/13/2024

Title

Related Topics

Radiation therapy, Medical physics, Monoclonal antibodies, Lung disorders, Radiobiology

Status

Grant

Latest Broncus Medical News

Broncus acquires Chinese pulmonary device company Hangzhou Jiangliang

Dec 1, 2023

Dec. 1, 2023 Broncus Holding Corp. subsidiary Broncus Hangzhou is acquiring Chinese medical device company Hangzhou Jingliang in the form of an equity transfer agreement for ¥5.4 million (US$758,000). The move will strengthen Broncus’ R&D capabilities in the flexible robotic space and will allow the company to offer pulmonology diagnostics and therapeutic solutions covering the complete product life cycle.

Broncus Medical Frequently Asked Questions (FAQ)

  • When was Broncus Medical founded?

    Broncus Medical was founded in 1997.

  • Where is Broncus Medical's headquarters?

    Broncus Medical's headquarters is located at 125 Nicholson Lane, San Jose.

  • What is Broncus Medical's latest funding round?

    Broncus Medical's latest funding round is IPO.

  • How much did Broncus Medical raise?

    Broncus Medical raised a total of $276.1M.

  • Who are the investors of Broncus Medical?

    Investors of Broncus Medical include FountainVest Partners, Summer Capital, Exome Asset Management, Valiance Capital, Qiming Venture Partners and 37 more.

  • Who are Broncus Medical's competitors?

    Competitors of Broncus Medical include Reva Medical, Avedro, Calibra Medical, Uptake Medical, Sonoma Orthopedic Products and 7 more.

Loading...

Compare Broncus Medical to Competitors

V
Varix Medical

Varix Medical Corporation, located in Sunnyvale, Calif., is a medical device company focused on developing products for the minimally invasive treatment of chronic venous insufficiency, commonly referred to as "varicose veins." For patients with advanced stages of varicose veins, laser- and RF-based (radiofrequency) treatments have been developed, but each device has deficiencies making them less-than-optimal solutions. Varix Medical's platform technology will enable physicians to efficiently and effectively treat more types of diseased veins than is currently possible when using either laser or RF devices. Additional treatable vessels include tortuous sub-truncal vessels and other visible smaller varicose veins. The Varix platform employs a vapor-based endovenous ablation system that will consist of a disposable catheter, a catheter introducer or delivery system, and a reusable vapor generator. RCT and Coronis Medical Ventures LLC., formed Varix in August 2007 and acquired the technology under license from Tsunami MedTech LLC. Coronis and RCT have been the primary in investors in Varix.

Endologix Logo
Endologix

Endologix is a company focused on the development and manufacturing of minimally invasive treatments for aortic disorders, operating within the medical devices industry. The company's main offerings include a variety of endovascular stent grafts, which are used for the treatment of abdominal aortic aneurysms (AAA), a condition characterized by a weakening of the wall of the aorta that can lead to a balloon-like enlargement. Endologix primarily serves the healthcare sector, particularly in areas related to vascular disease and aortic disorders. It was founded in 1992 and is based in Irvine, California.

R
Reva Medical

Reva Medical is a company that focuses on bioresorbable polymer technologies within the vascular applications sector. The company's main offerings include the development and sale of implantable medical devices designed to treat vascular conditions such as coronary and peripheral artery disease. These devices, made from a proprietary polymer, are designed to support the artery during the healing process and then naturally dissolve in the body. It was founded in 1998 and is based in San Diego, California.

C
Chestnut Medical Technologies

Chestnut Medical Technologies specializes in the development and supply of metal targets for shooting practice within the firearms industry. Their products are designed to enhance the shooting skills of individuals and organizations by providing durable, safe, and versatile targets for various shooting exercises. These targets come in different shapes, sizes, and can be either mobile or stationary, catering to a wide range of shooting practice needs. It is based in Menlo Park, California.

InfraReDx Logo
InfraReDx

InfraReDx is a company that focuses on the development of high-resolution intravascular imaging technologies, operating within the healthcare and technology sectors. The company's main offerings include imaging systems and devices that provide detailed structural views and plaque compositional analysis, aiding in the treatment of vascular diseases. InfraReDx primarily serves the healthcare industry, particularly sectors dealing with heart and vascular diseases. It was founded in 1998 and is based in Burlington, Massachusetts.

A
Arbor Surgical Technologies

Arbor Surgical Technologies, Inc. with facilities located in Irvine and Portola Valley, CA (USA), is a privately held cardiovascular medical device company focused on the heart valve replacement market. Founded in 2002 by Dr. Thomas J. Fogarty and noted heart valve designer, Ernie Lane, Arbor is developing multiple technologies that have the potential to deliver significant clinical benefit to patients worldwide. Arbor intends to develop and commercialize its core technologies in varying combinations, giving the company the opportunity to create a broad portfolio of product offerings. Currently in clinical trials, Arbor is developing a tissue heart valve family of products designed for improved performance over existing valves and compatible implantation tools that simplify and speed valve replacement surgery. Arbor Surgical Technologies mission is to simplify cardiac valve surgery through the innovative development of a less invasive, unique implantation system and valves with superior performance and durability. Partnering with physicians, we will improve patient recovery by less invasive techniques and reduced surgery time. Ethical behavior with employees, surgeons, patients and suppliers is the keystone to our success.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.